Ligand Pharmaceuticals (LGND) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of$1.13 per share. This compares to earnings of $2.28 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 6.19$0.58 per share when it actually produced earnings of $1.05, delivering a surprise of 81.03%. Over the last four quarters, th ...